EUVIMEDEUVIMED entdecken
Crossref

A Validated, Stability‐Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance

Lixiang Zhang iD, Xinyu Li, Jiansong Zhang, Xiao Wang, Yuqing Fu

Biomedical Chromatography · 2025-07 · 39 (7)

DOI: 10.1002/bmc.70118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 29.05.2025. Verfasst von Lixiang Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen JXBio Pharmaceutical Co., Ltd, Shenzhen, China. Hauptthemen laut MEDLINE: Liraglutide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liraglutide, an analog of glucagon‐like peptide‐1, is a treatment for the management of type 2 diabetes mellitus and obesity. In this study, we developed and validated a straightforward, sensitive, and reproducible gradient reverse‐phase high‐performance liquid chromatographic method for the separation and quantification of related substances in liraglutide drug substance. A C8 column was employed as the chromatographic column, with a mobile phase comprising phosphate buffer solution and acetonitrile. Under optimized chromatographic conditions, five specific impurities within liraglutide could be efficiently separated simultaneously. The resolution between main peak and each impurity was greater than 1.0, and the tailing factor of the main peak was less than 1.0. This method exhibited high sensitivity and enabled quantitative determination of both liraglutide and each impurity, thereby effectively ensuring the quality control of liraglutide products. The developed method is validated in accordance with the guidelines set by the International Conference on Harmonization regarding specificity, linearity, limit of detection, limit of quantification, accuracy, precision, and robustness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideChromatography, High Pressure LiquidReproducibility of ResultsLimit of DetectionLinear ModelsDrug ContaminationDrug StabilitySensitivity and Specificity

Stichwörter der Autor:innen

determinationglucagon‐like peptide‐1liraglutiderelated substances

Substanzen

Liraglutide

Autor:innen und Institutionen

  • Shenzhen JXBio Pharmaceutical Co., Ltd, Shenzhen, China.
  • Shenzhen JYMed Technology Co., Ltd, Shenzhen, China.

ORCID-Profile: Lixiang Zhang

Förderung

  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Zhang, L., Li, X., Zhang, J., Wang, X., & Fu, Y. (2025). A Validated, Stability‐Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance. Biomedical Chromatography, 39(7). https://doi.org/10.1002/bmc.70118

Vancouver

Zhang L, Li X, Zhang J, Wang X, Fu Y. A Validated, Stability‐Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance. Biomedical Chromatography. 2025;39(7). doi:10.1002/bmc.70118

BibTeX
@article{Zhang2025,
  author = {Zhang, Lixiang and Li, Xinyu and Zhang, Jiansong and Wang, Xiao and Fu, Yuqing},
  title = {A Validated, Stability‐Indicating HPLC Method for the Simultaneous Determination of Five Related Substances in Liraglutide Drug Substance},
  journal = {Biomedical Chromatography},
  year = {2025},
  volume = {39},
  number = {7},
  doi = {10.1002/bmc.70118}
}
Kostenlos starten →